Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment
NCT06679920
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Bladder Cancer
Interventions
DEVICE:
Optical coherence tomography
Sponsor
Amsterdam UMC